Mereo’s shareholders back OncoMed takeover

GlaxoSmithKline, Bayer and Celgene, whilst raising hundreds of millions of dollars in funding. ... GSK-partnered tarextumab for pancreatic cancer was the first casualty in 2016, followed by Celgene-partnered demicizumab a year later, and then Bayer

Allergan wins support against dissident shareholders

Allergan has also taken other measures to placate investor sentiment, including assembling a new a new M&A committee led by former Celgene CEO Bob Hugin.

Janssen’s CAR-T gains PRIME status in Europe

Bluebird Bio and Celgene and currently seen as the frontrunners with their late-stage CAR-T candidate bb21217, while Celgene has a similar challenger in development with Juno.

BMS closes on Celgene merger after rebel investors bow out

vote against the company’s proposed acquisition of Celgene on the company’s white proxy card.”. ... Shares in BMS tracked down 0.27% on Friday after Starboard pulled its proxy, while Celgene was up almost 8%.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]